PRECISIONscientia
PRECISIONscientia (operating as Precision AQ) is a full-service medical communications and market access agency serving pharmaceutical and biotechnology clients as Agency of Record for drug launches, label expansions, and HEOR evidence generation.
- Company typePrivate
- Founded2002
- HeadquartersYardley, United States
- Headcount101–250
- GTM typeB2B
- OfferingServices
What PRECISIONscientia does
PRECISIONscientia, doing business as Precision AQ, is a full-service medical communications and market access agency serving pharmaceutical and biotechnology companies. Founded in 2002 and headquartered in Yardley, Pennsylvania, the firm operates as an Agency of Record (AOR) for drug launches and label expansions, and claims involvement in approximately 50% of all FDA-approved drug launches in 2024. The primary customer segment is large pharmaceutical companies; biotechnology innovators form a secondary segment requiring support for therapy commercialization.
The firm's service portfolio is organized into six solution lines: Value & Access (Access Consulting, HEOR, Market Access Agency, Market Access Data Solutions), Medical Communications (Peer-to-Peer Marketing, Medical Affairs, Learning & Development), Investor Relations and External Communications, Brand Strategy and Marketing, Data Insights and Analytics, and Product Offerings. The proprietary product stack includes AccessGenius (payer and market access intelligence), OncoGenius (oncology-specific market intelligence), Data Solutions (patient, payer, provider analytics), EHR Solutions (electronic health record integration), and Omnichannel Solutions (multi-channel HCP, payer, patient engagement). Therapeutic specialization covers Immunology, Neurology, Oncology, Rare Disease, and Cardio Renal Metabolic. The technology is positioned as a data-integration and analytics platform rather than a discrete AI product.
Revenue is generated through professional services on a custom-quote basis, structured primarily as recurring AOR engagements. Distribution is direct enterprise field sales to pharma and biotech leadership; top-of-funnel marketing relies on LinkedIn, an integrated resources hub (reports, blog, videos), newsletter subscriptions, and industry events. Headcount sits at 101–250 employees, placing the firm in the mid-sized specialty agency tier. No public funding rounds, executive roster, M&A history, customer logos, or audited revenue figures are disclosed in the source data.
PRECISIONscientia firmographics
Firmographics- Name
- PRECISIONscientia
- Legal name
- Precision AQ
- Website
- https://precisionscientia.com
- Company type
- Private
- Founded year
- 2002
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- PRECISIONscientia (operating as Precision AQ) is a full-service medical communications and market access agency serving pharmaceutical and biotechnology clients as Agency of Record for drug launches, label expansions, and HEOR evidence generation.
- Ownership category
- akta.pro rank
PRECISIONscientia industry classification
Industry- Product category
- Pharmaceutical Marketing Services
- NAICS
- Other Scientific and Technical Consulting Services (54169), Custom Computer Programming Services (541511), Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (51821), Other Scientific and Technical Consulting Services (541690)
- SIC
- Services-Computer Programming, Data Processing, Etc. (7370), Services-Prepackaged Software (7372)
- akta.pro primary industry
- Medical Affairs Scientific Communications (MSL Support/Scientific Response) (HLAGALAF)
- akta.pro secondary industries
- Market Access, Pricing & Reimbursement (Evidence Generation) FSP (HLAGAOAN), Data Management, Biostatistics & Statistical Programming FSP (HLAGAOAB), Healthcare & Life Sciences PR (MPAAADAD)
Keywords
Where PRECISIONscientia is headquartered
LocationHeadquarters
- HQ city
- Yardley
- HQ country
- United States
- HQ region
- North America
Markets served
PRECISIONscientia business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Others
Revenue model
- Professional Services: Consulting and agency services including access consulting, HEOR, medical communications, investor relations, brand strategy, marketing, and data analytics. Operates as an Agency of Record providing ongoing strategic support for pharma commercialization.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels4 records
PRECISIONscientia product offering
Product offeringCore offering
PRECISIONscientia (operating as Precision AQ) is a full-service medical communications and market access agency that helps pharmaceutical and biotechnology companies commercialize therapies. It delivers services spanning HEOR evidence generation, payer strategy, medical communications, medical affairs, brand strategy and marketing, investor relations, and data analytics, often serving as the Agency of Record for drug launches and label expansions. Its offering is augmented by proprietary technology products such as AccessGenius, OncoGenius, Data Solutions, EHR Solutions, and Omnichannel Solutions that evaluate market potential and support HCP, payer, and patient engagement.
Product overview
Precision AQ offers a suite of technology products for pharmaceutical and biotech commercialization. The product portfolio includes AccessGenius, Data Solutions, EHR Solutions, Omnichannel Solutions, and OncoGenius—technology products that power HCP (healthcare provider), payer, and patient engagement by evaluating market potential, streamlining targeting, and supporting commercial impact. These products are complemented by consulting services including Access Consulting, HEOR, Market Access Agency, Medical Communications, Brand Strategy & Marketing, Investor Relations & External Communications, and Data, Insights, & Analytics.
Differentiator
Problem solved
Functional benefit
Products and services
- AccessGenius Technology product that powers HCP, payer, and patient engagement by evaluating market potential and supporting commercial impact for pharmaceutical and biotech clients.
- OncoGenius Specialized technology product delivering oncology-specific market intelligence and data solutions for oncology market access and commercialization support.
- Data Solutions Technology product providing data analytics and insights for patient, payer, and provider segments to support market access and commercial success.
- EHR Solutions Technology product providing electronic health record integration and data solutions for healthcare data integration and analysis.
- Omnichannel Solutions Technology product enabling multichannel engagement strategies for HCP, payer, and patient outreach across pharmaceutical and biotech commercial teams.
- Value & Access Services Agency service line encompassing access consulting, HEOR, and market access agency services, delivering payer strategy, payer marketing, and evidence generation for pharmaceutical clients.
- Medical Communications Services Agency service line covering peer-to-peer marketing, medical affairs, and learning and development communications for life sciences audiences.
- Investor Relations & External Communications Service line delivering investor relations and public relations support to facilitate pharma and biotech engagement with the financial community and external audiences.
- Brand Strategy & Marketing
Quantifiable outcome
- 50% of all FDA-approved drugs in 2024 were launched with Precision AQ
Companies that use PRECISIONscientia
Customer profileNamed customers1 record
Segments2 records
Ideal customer profiles2 records
PRECISIONscientia technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
PRECISIONscientia partnerships and signals
Strategic signalScale indicators2 records
Recent moves5 records
Expansion highlights5 records
PRECISIONscientia competitors and assessment
Company assessmentDirect peers
- Real Chemistry: Real Chemistry (formerly W2O) is a healthcare-focused agency combining data, analytics, PR, and medical communications for pharma and biotech, overlapping Precision AQ on communications, brand strategy, and data-driven engagement.
- ZS Associates: ZS Associates is a consulting firm specializing in pharma market access, sales, and data analytics — directly comparable to Precision AQ's access consulting, payer strategy, and data solutions practices.
- Klick Health: Klick Health is a large independent health agency offering brand strategy, medical communications, omnichannel engagement, and data services — directly comparable to Precision AQ's brand, communications, and omnichannel offerings.
- EVERSANA: EVERSANA is an integrated pharma commercialization partner offering market access, medical communications, HEOR, and data/analytics — directly comparable to Precision AQ's end-to-end commercialization stack and customer base.
- Fishawack Health: Fishawack Health is a medical communications and commercialization agency serving pharma across therapeutic areas, with deep scientific communications and HEOR offerings closely aligned to PRECISIONscientia's remit.
- Syneos Health (ConcentricLife / Inotiv): Syneos Health combines clinical and commercial services, including medical communications and market access, serving similar pharma/biotech clients with an AOR-style commercialization model.
Broad incumbents
- Publicis Health: Publicis Health operates a global portfolio of health-focused agencies (including Saatchi & Saatchi Health, Digitas Health) covering medical communications, brand, and data — a broad incumbent competing for the same enterprise pharma AOR business.
- IQVIA: IQVIA is the largest life sciences services conglomerate, spanning RWD, HEOR, market access, and commercial services — a broad incumbent that overlaps with most of Precision AQ's service portfolio, particularly data and access.
- Havas Health & You: Havas Health is a global health communications and marketing network offering medical communications, advertising, and brand strategy — overlapping Precision AQ's brand, communications, and investor relations offerings at greater scale.
- McKinsey & Company (Pharma Practice): McKinsey's pharma and medical products practice provides market access, HEOR, and commercial strategy at the largest scale — a broad incumbent whose payer/HEOR work competes with Precision AQ's access consulting and HEOR teams.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
PRECISIONscientia social profiles
Digital presencePRECISIONscientia financial estimates
Financial estimateRevenue estimate
Valuation estimate
PRECISIONscientia leadership team
Management profileNumber of profiles
PRECISIONscientia funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
PRECISIONscientia M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about PRECISIONscientia
What does PRECISIONscientia do?
PRECISIONscientia (operating as Precision AQ) is a full-service medical communications and market access agency that helps pharmaceutical and biotechnology companies commercialize therapies. It delivers services spanning HEOR evidence generation, payer strategy, medical communications, medical affairs, brand strategy and marketing, investor relations, and data analytics, often serving as the Agency of Record for drug launches and label expansions. Its offering is augmented by proprietary technology products such as AccessGenius, OncoGenius, Data Solutions, EHR Solutions, and Omnichannel Solutions that evaluate market potential and support HCP, payer, and patient engagement.
Is PRECISIONscientia a public or private company?
PRECISIONscientia is a private company. It is classified as unknown and is currently operating.
When was PRECISIONscientia founded?
PRECISIONscientia was founded in 2002. It employs 101 to 250 people.
Where is PRECISIONscientia based?
PRECISIONscientia is headquartered in Yardley, United States, in the North America region.
How does PRECISIONscientia make money?
One revenue line is on record: professional Services.
Who are PRECISIONscientia's main competitors?
Direct peers on record are Real Chemistry, ZS Associates, Klick Health, EVERSANA, Fishawack Health and Syneos Health (ConcentricLife / Inotiv). Broad incumbents are Publicis Health, IQVIA, Havas Health & You and McKinsey & Company (Pharma Practice).
Does PRECISIONscientia have an API?
No public API is recorded for PRECISIONscientia.
What industry is PRECISIONscientia in?
PRECISIONscientia's product category is Pharmaceutical Marketing Services. Its primary akta.pro industry code is HLAGALAF, Medical Affairs Scientific Communications (MSL Support/Scientific Response), with a secondary code of HLAGAOAN, Market Access, Pricing & Reimbursement (Evidence Generation) FSP. Its NAICS code is 54169 and its SIC code is 7370.